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The cardiac profile of 38 patients readmitted to the hos-
pital with the clinical and radiologic findings of pul-
monary artery hypertension and right ventricular failure
2 months after ingestion of toxic rapeseed oil was de-
termined with M-mode and two-dimensional echocar-
diography, pulsed Doppler flow studies and right and
left heart catheterization and ventriculography. The
echocardiogram and pulsed Doppler recordings revealed
right ventricular enlargement in 84% of the patients,
indirect evidence of pulmonary artery hypertension in
76% and tricuspid insufficiency in p %. At cardiac cath-
eterization (n = 11) the mean (± standard deviation)
pulmonary artery pressure was 40 ± 9 mm Hg, mean
pulmonary systemic vascular resistance ratio was 0.45
Because of "sindrome toxico," European public health of-
ficials are facing their most serious and potentially cata-
strophic epidemic since thalidomide. More than I million
Spanish citizens may have been exposed (1) to toxic levels
of oleoanilide, a chemical by-product formed when indus-
trial grade rapeseed oil reacts with aniline and acetanilide
dyes used to mark the oil as unfit for human consumption.
Since the illegal sale of the tainted rapeseed oil in the sum-
mer of 1981 for use as cooking oil, more than 15,000 chil-
dren and adults have been hospitalized in the Madrid area
complaining offever, dyspnea, cough, skin rash and a spec-
trum of gastric and neurologic symptoms (2). The most
consistently observed laboratory findings were marked blood
eosinophilia and radiographic interstitial pneumonitis. Au-
topsy studies performed on many of the more than 250
patients who died during their acute illness, usually of hy-
poxic respiratory failure complicating noncardiogenic pul-
monary edema, showed a generalized small vessel leuko-
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± 0.12 and mean right ventricular end-diastolic pres-
sure was 13 ± 4 mm Mg.Pulmonary artery hypertension
was sustained after the acute administration of 100%
oxygen and persisted in six patients who were restudied
within 6 months. Cardiac index and left heart pressures
were normal in all but one patient. The contrast ven-
triculographic studies revealed right ventricular dilation
in all patients, tricuspid regurgitation in three patients
and a normal left ventricular contraction pattern in all
but one patient.
The data confirm that symptomatic pulmonary artery
hypertension and associated right ventricular dysfunc-
tion can complicate toxic rapeseed oil ingestion and that
these findings persist for at least 6 months.
cytoclastic vasculitis with secondary venous and arterial
thromboses and hemorrhagic infarcts in the lungs, heart,
skin, muscle, liver, kidney, thyroid and nervous tissues.
Approximately 10% of the surviving patients suffered a
recrudescence of fever, myalgias and neurologic and pul-
monary symptoms within 2 months of their original expo-
sure to the rapeseed oil. In spite of complete radiologic
resolution of the acute interstitial pneumonitis, 20% of these
patients had evidence of residual pulmonary fibrosis with
impaired alveolar-arterial gas exchange (2). Many patients
subsequently developed symptoms of pulmonary hyperten-
sion and right ventricular failure.
In this report, we describe the clinical, echocardio-
graphic, hemodynamic and pathologic features of 38 pa-
tients with pulmonary hypertension and right ventricular
dysfunction after "sindrome toxico."
Methods
Patients. From May to October 1981, 465 patients were
admitted to the Hospital Provincial of Madrid with the di-
agnosis of "sindrome toxico" based on a history of recent
ingestion of rapeseed oil and one or more of the following
findings: 1) diffuse interstitial pneumonitis on chest X-ray
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film, 2) a total eosinophil count greater than 500 cells!JLliter,
and 3) severe myalgias . Of these patients, 108 (23%) were
less than 14 years of age.
In July 1981, approximately 2 months after the index
case was diagnosed, 65 patients developed clinical and
radiologic findings of pulmonary hypertension and right
ventricular dilation. Of the 65 patients, 38 had M-mode and
two-dimensional echocardiography performed and 11 had
cardiac catheterization with angiography and right and left
heart hemodynamic measurements at rest , after exercise and
after inhalation of 100% oxygen. The echocardiographic
and catheterization data were obtained between 1 to 4 months
after the initial symptoms of sindrome toxico. Echocardio-
graphic data were not obtained prospectively in all patients.
However, the 27 patients who did not have echocardiog-
raphy or cardiac catheterization performed were similar clin-
ically to the 38 patients who were studied and had a similar
evolution of their illness .
These 38 patients consisted of 19 children (aged 2 to 14
years) and 19 adults (aged 16 to 67 years) , all of whom had
clinically recovered 1 to 4 months after a well documented
case of sindrome toxico. Twenty-two were female and 16
male; the mean age ± standard deviation was 21 ± 17
years .
All patients had a detailed history and complete physical
examination on admission to the Hospital Provincial of Mad-
rid. Blood was drawn for hematologic measurement (com-
plete blood count, white blood cell differential , sedimen-
tation rate and platelets) and biochemical analysis that in-
cluded hepatic transaminases. Each patient had a serial 12
lead electrocardiogram and posteroanterior and lateral chest
X-ray films that were compared with films taken during
previous hospital admissions. Arterial blood gases were
measured at rest with all patients breathing room air.
Echocardiography. Echocardiographic examination was
performed in all 38 patients using both a Unirade-100 (M-
mode) and ATL Mark 5 (two-dimensional) apparatus.
Special attention was given to the size and function of the
right ventricle and the echocardiographic signs of pulmonary
hypertension. Pulmonary hypertension was considered if the
maximal right ventricular!left ventricular diameter exceeded
0.75 either in the short-axis view at the level of the chordae
tendinae or in the four chamber apical view in children , or
if the A wave in the pulmonary valve M-mode echocardio-
gram was absent (3). Pulsed Doppler recordings were made
during two-dimensional echogram s to detect systolic tur-
bulence in the right atrium, indicating tricuspid insuffi-
ciency , or right ventricular diastolic turbulence suggestive
of pulmonary regurgitation.
Cardiac catheterization. Eleven patients underwent
elective right and left heart catheterization using a femoral
approach to measure aortic, pulmonary artery, pulmonary
wedge and right and left ventricular pressures. In nine pa-
tients, aortic and pulmonary artery pressures were measured
before and after inhalation of 100% oxygen for 5 minutes
and again after 5 minutes of supine bicycle exercise at a
constant energy level of 50 watts. Three of the nine patients
were hypoxemic at rest. Cardiac output was measured at
rest using the Fick technique. The basal cardiac index and
pulmonary and systemic vascular resistances were calcu-
lated using standard formulas from the measured data (4).
During the initial study after the previously mentioned
hemodynamic measurements had been made, one patient
was given nifedipine, 10 mg. and another hydralazine, 20
mg, by infusion into the pulmonary artery; hemodynamic
measurements were then repeated. Six patients gave consent
for repeat catheterization within 6 months after the first study
in which all patients had bicycle exercise and five patients
received 100% oxygen .
Histology. Detailed histologic examination was per-
formed on right ventricular endocardial biopsy specimen
obtained during cardiac catheterization in two patients and
at autopsy in one patient who died 2 days after cardiac
catheterization from anaphylactic shock produced by a pen-
icillin injection .
Statistical analysis. Paired hemodynamic data were
compared using the Wilcoxon signed ranks test for non-
parametric dimensional data. A probability (p) value less
than 0.05 (two tailed) was considered significant.
Results
Clinical features. The clinical findings and routine non-
invasive laboratory data at the time of admission for cardiac
study are summarized in Table 1. In 76% of the 38 patients
studied, there was a history of new exertional dyspnea on
minimal (16 patients) or moderate effort (13 patients). Half
of the patients presented with signs of right ventricular fail-
ure, including a gallop rhythm and jugular venous distension
in 23 (61%), peripheral edema in 9 (23%) and the murmur
of tricuspid insufficiency in 5 (13%). Thirty-four patients
(89%) had signs of pulmonary artery hypertension, includ-
ing a prominent pulmonic component of the second heart
sound, and 9 (23%) had central cyanosis. Twenty-two pa-
tients had evidence of concomitant neurologic dysfunction
such as muscle atrophy , weakness and rigidity, somnolence
and behavioral changes (Fig. I). Among the less prominent
systemic complaints were a persistent diffuse , pruritic, mor-
billiform exanthem in five patients and severe weight loss
in two patients.
Admission laboratory data revealed blood eosinophilia
(> 500 cells!JLliter) in 34 patients as well as rest hypoxemia
(pulmonary artery oxygen pressure < 70 mm Hg) in 19 and
hepatic transaminase elevation (serum glutamic-oxaloacetic
[SOOT] and pyruvic [SOPT] transminase) in 3.
Radiologic findings. In 36 patients, the extensive in-
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No. = number; P, = pulmonary component of second hean sound. PaD, =
pulmonary artery oxygen pressure; RV = right ventricular.
Table 1. Clinical Findings and Routine Laboratory Data in
38 Patients
Clinical findings
Exertional dyspnea (>2/4)
Right ventricular failure (gallop.
jugular distension)
Prominent P2
Peripheral edema
Cyanosis
Murmur of tricuspid insufficiency
Exanthem
Weight loss
Neurologic dysfunction
Laboratory data
Blood eosinophilia (>500/~l)
Rest hypoxemia (Pa02 < 70 torr)
Hepatic transaminase elevation
Chest radiography
Interstitial pattern in acute phase
Cardiomegaly (cardiothoracic ratio > 50%)
Pulmonaryartery prominence
Electrocardiography
RV hypertrophy
ST-T wave abnormalities
Sinus tachycardia
Right axis deviation
Atrial fibrillation
Normal tracing
No. (% )
29 (76)
23 (6 \)
34 (89)
9 (23)
9 (23)
5 (13)
5 (13)
2 (5)
22 (58)
34 (89)
19 (50)
3 (3)
36 (95)
24 (63)
21 (55)
21 (55)
19 (50)
18 (47)
17 (45)
I (3)
5 (13) Figure 1. Severe muscular atrophy in a 12 year old girl with
neurologic manifestations of sindrome toxico.
terstitial infiltrates observed on chest X-ray films taken dur-
ing the acute illness had resolved completely by the time
of cardiac investigation at least 4 weeks later. Radiologic
cardiomegaly (cardiothoracic ratio> 50%) was present in
24 patients and 21 had pulmonary artery prominence with
pruning of peripheral vessels. All patients had at least one
previous chest X-ray film in which the cardiac silhouette
and pulmonary artery size were normal (Fig. 2).
Electrocardiographic findings. Admission electrocar-
diograms showed changes of right ventricular hypertrophy
(RiS amplitude ratio > 1 in lead VI , S wave in V5 and V6)
in 21 patients combined with right axis deviation (axis >
+ 90%) in 17 patients. Half the patients had repolarization
abnormalities and 18 (47%) had sinus tachycardia. One
patient had new atrial fibrillation. In only five patients was
the admission tracing within normal limits .
Echocardiographic findings (Table 2). Thirty-two pa-
tients had a maximal right ventricular/left ventricular di-
ameter ratio greater than 0.75 on two-dimensional echo-
cardiography. Twenty-nine patients had loss of the pulmonary
valve A wave and mid-systolic closure of the pulmonary
valve. Among the 30 patients in whom pulsed Doppler flow
studies were performed , systolic right atrial turbulence sug-
gesting tricuspid insufficiency was observed in 4 (13%), and
diastolic right ventricular turbulence of the type seen with
pulmonary insufficiency occurred in I (3%).
Cardiac catheterization findings (Table 3). All II pa-
tients who underwent right and left heart catheterization
between 1 and 6 months after the onset of the acute syn-
drome had some degree of pulmonary hypertension under
basal conditions, as evidenced by an increase in mean pul-
monary artery pressure (40 ± 9 mm Hg). The increase in
pulmonary vascular resistance was reflected in the group 's
mean pulmonary to systemic vascular resistance ratio (Rpl
Rs) which was three times the upper limit of normal (0.45
versus 0 .15). Right ventricular end-diastolic pressure was
slightly increased at rest (13 ± 4.1 mm Hg), but mean
arterial pressure, cardiac index and left heart (pulmonary
capillary wedge and left ventricular end-diastolic) pressures
remained within the normal range. Although administration
of 100% oxygen for 5 minutes caused a decrease in pul-
monary artery pressure in seven of nine patients, the average
decrease was small (from 40 to 36 mm Hg) and not statis-
tically significant. Five minutes of bicycle exercise at a
constant energy level (50 watts) produced a moderate in-
crease in mean pulmonary , right ventricular end-diastolic
and systemic arterial pressures (p < 0.0 I).
A comparison between the initial and recatheterization
data fr om six patients is presented in Table 4. Within 6
months after the first hemodynamic study, all pulmonary
artery pressures and mean pulmonary to systemic vascular
resistance ratios remained elevated, but the mean value had
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Figure 2. Sequential chest X-ray films in a patient who developed
pulmonary hypertension and cardiomegaly after toxic rapeseed oil
ingestion. The diffuse interstitial pneumonitis seen in the acute
phase of the illness (A) resolved after 4 weeks (8) followed by
radiologic evidence of pulmonary hypertension and cardiomegaly
2 months later (C).
Table 2. Echocardiographic Findings and Results of Pulsed
Doppler Flow Studies
decreased from 34.2 to 29.7 mm Hg and 0.38 to 0.25,
respectively, (p > 0.05). Mean pulmonary capillary wedge
and left ventricular end-diastolic pressures for the group
were unchanged at recatheterization with the exception of
an II year old boy whose preexisting left ventricular dys-
function had worsened during the interval between studies
(a pulmonary capillary wedge pressure increase from 14 to
40 mm Hg). A mild but insignificant increase in mean car-
diac index (2.63 to 3.05 liters/min per rrr') and arterial
pressure (92.3 to 108.0 mm Hg) was observed at restudy.
Oxygen administration (five patients) and bicycle exercise
Echocardiography
Total no. patients
RV enlargement
Pulmonary artery hypertension
Systolic mitral prolapse
Pericardial effusion
Pulsed Doppler recording
Total no. patients
RA systolic turbulence
RV diastolic turbulence
No. = number. RA = nght atnal ; RV = nght ventricular
No. (%)
38 (100)
32 (84)
29 (76)
28 (74)
9 (23)
30 (100)
4 (13)
I (3)
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Table 3. Hemodynamic Data From II Patients With Sindrome Toxico
Pulmonary Artery Pressure Aortic Pressure
SID (mean) RVEDP SID (mean)
Mean
Case R O2 E R E PCW R O2 E Rp/Rs CI LVEDP
50/29 50127 70/36 II 20 9 140/105 160/115 0.32 1.7 12
(34) (36) (52) (110) (130)
2 56/25 50/20 86/36 8 II 8 138/84 130/84 1801110 0.32 3.1 6
(36) (30) (58) (110) (93) (140)
3 60/24 10 18 110/80 0.45 2.0 10
(42) (92)
4 58/30 48129 72/39 14 25 8 100175 95/60 72138 0.5 2.6 14
(42) (36) (52) (82) (83) (58)
5 70/40 64130 85/45 16 35 94179 100/80 120/100 0.5 1.9 10
(52) (50) (78) (82) (94) (110)
6 50128 58132 80/47 16 16 12 90170 100170 130/90 0.4 2.5 12
(38) (43) (56) (80) (80) (110)
7 50128 45/24 80/50 16 28 14 90170 94170 130/88 0.39 2.6 14
(32) (36) (58) (82) (78) (112)
8 70/36 59/28 78/38 15 100/80 105170 100170 0.6 2.9 15
(48) (38) (58) (78) (88) (88)
9 70/40 18 II 98170 0.67 1.8 12
(55) (86)
10 48120 44/18 76/38 10 13 90/60 100/60 140/100 0.5 3.4 10
(34) (26) (56) (74) (80) (113)
II 35/20 31116 5 12 118/69 106170 140/90 0.31 3.0 12
(27) (26) (86) (89) (110)
Average 56/29 50125 78/41 106177 104171 130/89
Mean 40 36 59 13 20 10 88 86 108 0.45 2.5 12
SD ± 9 ± 8 ± 8 ± 4 ± 8 ± 2 ± 12 ± 6 ± 24 ± 0.12 ± 0.6 ± 3
All units of pressure measurement are mm Hg, cardiac index units of measurement are liters/min per m'.
CI = cardiac Index; D = diastolic: E = exercise: LVEDP = left ventncular end-diastolic pressure. 0, = after ]OO'k oxygen mhalanon, PCW = pulmonary capillary
wedge pressure. R = rest: Rp/Rs = pulmonary to systemic resistance ratio. RVEDP = right ventricular end-diastohc pressure: S = systolic: SD = standard deviation.
(six patients) produced hemodynamic changes similar to
those seen during the first catheterization.
One patient received a direct pulmonary artery infusion
of nifedipine, 10 mg. that failed to reduce either mean pul-
monary or systemic arterial pressure. The administration of
hydralazine, 20 mg, into the pulmonary artery of a second
patient resulted in systemic arterial hypotension (98/72 to
38 mm Hg) while worsening pulmonary arterial hyperten-
sion (mean 37 to 43 mm Hg).
Right ventricular angiography was performed after
hemodynamic monitoring in all 11 patients. Right ventric-
ular dilation was observed in II patients and tricuspid re-
gurgitationin 3 (2 moderate, I mild). Left ventriculography
was normal in all patients except for the II year old boy
who had biventricular failure with an apical wall motion
abnormality (Patient 7).
Histologic findings. Histologic examination of the two
right ventricularendomyocardialbiopsy specimenswas nor-
mal. An autopsy done on a patient who died of penicillin-
induced anaphylactic shock2 daysaftercatheterization showed
macroscopic evidence of right ventricular dilation and hy-
pertrophy. Microscopic examination of small and medium-
sized arterioles in the lungs, heart and kidneys revealed
thickening and hyalinization of the media, reduplication
without rupture of the internal elastic lamina, subintimal
edema and mononuclearcell infiltration producing irregular
narrowing of the vessel lumen (Fig. 3).
Discussion
Pathogenesis of pulmonary hypertension and right
ventricular failure. The noninvasive and hemodynamic data
reported in this study confirm that symptomatic pulmonary
hypertension and right ventricular dysfunction may com-
plicate the ingestion of toxic rapeseed oil. Although the
pathogenesis of pulmonary artery hypertension after acute
sindrome toxico remains to be elucidated, histologic studies
(2) implicate a generalized small vessel vasculitis with re-
sulting infarction and thrombosis in the pulmonary vascular
bed as the most plausible explanation. The effect of local
hypoxiaon thesepulmonaryvascular lesions is unclear. Half
the patientshad hypoxemiaat rest but oxygen administration
did not significantly reduce pulmonary artery pressures. Al-
thoughpulmonary hemodynamics were not significantly im-
proved at recatheterization, all but one patient had reduced
mean pulmonary artery pressure and mean pulmonary to
systemic vascular resistance ratio at restudy. This indicated
a partially reversible component of their increased pulmo-
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Table 4. Recatheterization Data in Six Patients With Sindrome Toxico
Pulmonary Artery Pressure Aortic Pressure
SID (mean) RVEDP SID (mean)
Mean
Case R O2 E R E PCW R O2 E Rp/Rs CI LVEDP
II 30/10 30/12 34/20 6 10 130/80 110 150/90 0.18 2.3 9
(18) (18) (25) (100) (100)
10 40/16 40/16 60/20 7 9 12 105/65 160/85 0.30 3.2 12
(25) (25) (40) (80) (110)
2 64/24 58/20 100/38 8 6 12 176/92 158/86 212/104 0.30 2.9 12
(32) (30) (68) (108) (102) (142)
55/32 40/20 44/18 15 15 1701105 170/110 1801120 18
(38) (30) (36) (130) (126) (140)
3 55/25 40/20 84/40 10 15 150/100 1701lI0 0.23 3.8 20
(35) (28) (55) (130) (130)
7 44/22 90/50 14 35 130/90 180111 0 40
(30) (65) (100) (135)
Average 50/24 44/21 78/33 114/78 108171 150/85
values at
initial study.
Table 3
Mean 34 31 56 10 17 92 85 121 0.38 2.6 II
SO :': 5 :': 5 :':3 :': 4 :': 7 :': 15 :': 7 :': 13 :': 0.08 :': 0.7 :': 3
Average 40118 42/18 69/31 144/89 164/98 175/103
values at
recatheteri-
zation
Mean 30 26 48 9 10 17 108 113 126 0.25 3.1 19
SO :': 7 :': 5 :': 17 :': 3 :': 5 :': 9 :': 19 :': 12 :': 17 :': 0.06 :': 0.6 :': II*
All units of pressure measurement are mm Hg; cardiac index units of measurement are liters/min per m' .
• Includ es one patient with a pulmon ary capillary wedge pressure of 35 mm Hg and a left ventricular end-diastolic pressure of 40 mm Hg. The mean pulmonary capillary
wedge pressure = 12.8 ( ~ 2.2) and mean left ventricular end-diastolic pressure = 14.2 ( ~ 4.6) without this panent, Abbreviations as in Table 3.
nary vascular resistance which may represent either early
resolution of pulmonary arteriolitis or attenuation of hypoxic
vasoconstriction, or both. Autopsy findings revealed a dif-
fuse vasculitis in myocardial arterioles; however, the echo-
cardiographic and catheterization data in this group of pa-
tients suggest that , in most cases, ventricular dilation and
failure were mainly confined to the right side of the heart
and the result of pulmonary vascular damage, not a primary
cardiomyopathy.
Toxicology. Dietary pulmonary hypertension is a rec-
ognized complication of chronic ingestion by animals and
human beings (5). Two species of crotalaria shrub are in-
digenous to the tropics , both of which have toxic pyrroli-
zidine alkaloids in their seeds . Crotalaria spectabilis con-
tains monocrolatine, and crotalaria fulva is rich in the
pyrrolizidine alkaloid , fulvine. Although hepatotoxicity is
the most prominent manifestation of the human crotalaria
endemic in the West Indies, rats and macae monkeys often
die of pulmonary hypertension and right ventricular failure
after chronic monocrolatine ingestion. Pathologic findings
in pulmonary vessels of these animals are similar to those
seen in advanced mitral stenosis, that is, necrotizing arte-
riolitis , medial hypertrophy and mass cell proliferation .
An epidemic of drug-induced pulmonary hypertension
occurred in Germany , Switzerland and Austria in the mid
1960s after the widespread use of the amphetamine-like
appetite suppressant, aminorex (5-amino-5-phenyloxazo-
line) (5,6). In contrast to patients with crotalaria toxicity ,
these patients had no hepatic damage and their pulmonary
pathologic features resembled those of primary pulmonary
hypertension, that is, plexiform lesions and intimal fibrosis.
Sporadic cases of pulmonary hypertension have been re-
ported in patients taking another anorexiant, fenfluramine
(7), and the oral hypoglycemic agent, phenformin (8), but
a cause and effect relation remains to be established. Fatal
pulmonary fibrosis has also been reported after ingestion of
Paraquat , a commonly used effective herbicide (9) . Pul-
monary edema often appears within days after ingestion and
pulmonary fibrosis 2 to 3 weeks later . The most common
cause of death from Paraquat poisoning is severe obliterative
pulmonary fibrosis followed by renal failure (10) .
Animal studies have not yet confirmed which of the many
proposed pathogenet ic mechanisms might explain the oc-
currence of pulmonary artery hypertension in patients with
sindrome toxico . The list of hypotheses includes direct al-
pha-adrenergic stimulation , lactic acidosis, the release of
endogenous catecholamines or vasoactive hormones and di-
rect damage by toxic hepatic metabolites.
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Figure 3. Cross section ofa pulmonary artery branch
vessel at autopsy showing thickening of the tunica
intima (arrows) from cellular hyperplasia with con-
comitant luminal reduction.
Although oleoanilide appears to be the major toxin in
rapeseed oil, other agents such as erucic acid (J J) have
been implicated. Plasma cell and monocytic infiltration of
vessel walls and blood eosinophilia point to an immune-
mediated vasculitis; however, oleoanilide's powerful oxi-
dant effect may directly damage vascular and lipid-rich tis-
sues such as myelin, thereby producing the concomitant
neurologic dysfunction seen in 58% of these patients. Fea-
tures of lipoid pneumonia similar to those occurring after
kerosene inhalation have been observed after rapeseed oil
exposure (2). Toxic fumes inhaled during cooking may rep-
resent another route of exposure.
Treatment. Therapy during the acute illness is largely
supportive. Physiotherapy and oxygen administration are
usually indicated and mechanical ventilation may be nec-
essary if respiratory failure supervenes. Antioxidant com-
pounds (vitamin E and glutathione) and corticosteroids have
been used empirically with varying results (l,2). Although
the use of corticosteroids during the acute illness is appealing
in view of possibility of an immune-mediated vasculitis,
their efficacy and impact on the natural history of the disease
is undetermined. No therapeutic agent, other than oxygen,
has been demonstrated to improve pulmonary hypertension
once it is established. Neither hydralazine nor nifedipine,
given to two patients in this study by direct pulmonary
infusion, produced any acute subjective or objective im-
provement in pulmonary hypertension.
Clinical course. Our recatheterization data demonstrate
that the course of pulmonary hypertension during the first
6 months after sindrome toxico is one of gradual but in-
complete resolution. Ifsignificant pulmonary vascular dam-
age occurs resulting in a sustained elevation in pulmonary
vascular resistance, progressive right ventricular impairment
may be anticipated during the long-term follow-up of these
patients.
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